Aa
A
A
Close
Avatar_universal
GS-4774: an HBV-Specific Therapeutic Vaccine
Safety, Tolerability, and Immunogenicity of GS-4774, an HBV-Specific Therapeutic Vaccine, in Healthy Volunteers - Data from AASLD Liver Meeting 2013

http://www.natap.org/2013/AASLD/AASLD_74.htm
Cancel
1 Answers
Page 1 of 1
Avatar_universal
Hi, GS-4774 demonstrated a favorable safety and immunogenicity profile in a previous Phase 1 clinical trial in patients with chronic hepatitis B virus (HBV) infection. This vaccine is aimed at declining the serum HBV surface antigen (HBsAg) in chronically infected patients. Regards.

Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Your Answer
Avatar_universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
GS-4774: an HBV-Specific Therapeutic Vaccine
Submit Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources
RSS Expert Activity
233488_tn?1310696703
Blank
Marathon Running Done Over Many Yea...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
233488_tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
748543_tn?1443740527
Blank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Hepatitis Answerers
Avatar_m_tn
Blank
stef2011
Italy
Avatar_m_tn
Blank
StephenCastlecrag
Australia
Avatar_m_tn
Blank
sorte
Poland
Avatar_f_tn
Blank
Royal36
Avatar_m_tn
Blank
Jatashankar
India
Avatar_f_tn
Blank
flyinsky
paris, France